SUMMARY Chloramphenicol (D-threo-2-dichloroacetamido-1-p-nitrophenylpropane-1, 3-diol) added to blood samples did not alter the observed shift in the red cell osmotic fragility curves as the samples were aged in vitro for 24 hours at 370C. Nor was the normal rate of loss of 2,3-diphosphoglycerate, ATP, or glutathione from the red cells affected by the presence of chloramphenicol over the same period. Consequently, this bacteriostatic agent can be added to blood samples taken under nonsterile conditions, such as from the heel of an infant, in order to preserve them from the effects of microbial contamination. In this way red cell osmotic fragility results can be obtained on non-sterile samples after their incubation at 37'C for 24 hours. A miniaturisation of the standard osmotic fragility procedure is described, which allows results to be produced from the small, non-sterile samples obtained by heel-prick of infants.
The osmotic fragility test of red blood cells is well established as a screening procedure in the diagnosis of red cell membrane abnormalities (Whitby and Hynes, 1935; Dacie and Vaughan, 1938) . Its application in the diagnosis of hereditary spherocytosis and other haemolytic disorders is well documented (Dacie, 1960) . It is of particular value in paediatric laboratory medicine where the early diagnosis of hereditary spherocytosis in the offspring of affected patients is important in their clinical management.
The interpretation of results in these cases is greatly helped by repeating the osmotic fragility measurements after incubating a sterile blood sample in vitro at 370C for 24 hours (Selwyn and Dacie, 1954) . In some cases red cells from a patient with hereditary spherocytosis will show an abnormal shift in the osmotic fragility curve only after such treatment, this being a reflection of the excessive loss of membrane lipid from affected cells (Reed and Swisher, 1966; Jacob, 1967) and their higher metabolic rate (Jacob, 1965) .
A laboratory problem encountered when producing osmotic fragility results on infant patients is that many paediatricians are reluctant to venepuncture these patients and prefer to obtain samples by heel-prick. Such samples are generally of smaller volume than required for standard osmotic fragility measurements and are not sufficiently free of contamination to be incubated at 370C for 24 hours without extensive denaturation.
Received for publication 30 January 1978 The following work was performed to show that the standard procedure for measuring red cell osmotic fragility (Dacie and Lewis, 1975) could be adapted to cater for microsamples, and that the bacteriostatic agent, chloramphenicol (CAP), could be used to maintain blood samples free from the effects of bacterial contamination without detriment to the red cells.
Material and methods

BUFFERED SODIUM CHLORIDE SOLUTIONS
Thecurrentlyavailableprotocols(eg, DacieandLewis, 1975) 
ANALYSIS OF METABOLITES
Red cell 2,3-diphosphoglycerate (DPG) was measured by the method of Nygaard and Rorth (1969) , which was modified and available as a commercial kit (Calbiochem).
Whole blood ATP was also measured using commercial kit reagents (Calbiochem) based on the method of Kornberg (1955) .
Red cell glutathione (GSH) was measured by the method of Beutler et al. (1963) .
Red cell lysates for the assay of metabolites were prepared from whole blood filtered through cellulose according to the procedure of Beutler (1975) . The filtered red cells were washed twice with iced saline and lysed in disodium-EDTA, 2-5 mmoles/1, pH 7 00. Samples of lysate were taken for analysis of GSH immediately on preparation; the remaining lysate was stored at -70'C until required for analysis of DPG.
BLOOD SAMPLES Blood samples were obtained from adults by venepuncture and divided into two parts. One part was defibrinated and handled under sterile conditions; the other was heparinised with 25 IU lithium heparin (preservative-free) per ml blood and treated with CAP solution, 5 ,ul for every 200 ,ul blood. Blood samples of 100-200 ,A were taken from infants by heel-prick into heparinised capillary tubes and treated with 5 ,ul CAP on receipt in the laboratory. Haemolysates for metabolite analyses were prepared, and osmotic fragility curves were measured on all samples within one hour of sampling. Samples containing CAP and sterile, defibrinated samples were also placed in an incubator at 37°C for 24 hours after which the measurements were repeated.
OSMOTIC FRAGILITY MEASUREMENTS
A minimum of 100 ,ul blood is required. A series of buffered salt solutions of osmolalities ranging from 33 to 315 mmoles/kg were prepared by mixing solutions A and B in different proportions. Solution osmolalities were calculated using equation (1). Three millilitres of each solution was pipetted into a disposable cuvette (1 cm light path x 1 cm x 4-5 cm, Ratiolab cat. 1101) followed by 2 ,ul blood. The mixtures were shaken and allowed to stand for 30 minutes at 20°C, and the remaining intact red cells were then centrifuged out of suspension at 1200 g for two minutes. The absorbance of the supernant fluid in each cuvette was read in a Unicam SP 1750 spectrophotometer at 415 nm without decanting, using solution B as blank.
Results
It was found that the standard method of osmotic fragility measurement (Dacie and Lewis, 1975) and the current method gave identical results for the same sample at one hour and 24 hours after sampling. Patients included normal adults and infants, and adults and infants with hereditary spherocytosis. A minor difference was observed in the osmotic fragility curves ofcapillary and venous samples taken from the same individual. Heparinised capillary samples maintained with CAP showed a small increase in median corpuscular fragility of 10-15 mmoles/kg (0 03-0 05 % NaCI) when compared with the corresponding venous sample after 24 hours. The fragility curves were identical at one hour after sampling (Figure) .
The combined effect of heparin with CAP on the concentrations of some major red cell metabolites was also insignificant. Table 1 lists the findings. No major disturbance of the red cell metabolism was obvious from these results. It is possible that heparinised samples maintained with CAP lost marginally less ATP and GSH than defibrinated sterile samples on incubation at 37°C for 24 hours (Table l) . However, these differences were slight and had no effect on the observed mean corpuscular fragility, nor on the overall shape of the fragility curve. (Danon et al., 1970; Luzzatto et al., 1970 Mitochondrial protein synthesis is inhibited by CAP (Kurtz, 1974) . A1-Aminolevulinic acid synthetase activity is altered in reticulocyte (Rosenberg and Marcus, 1974) and bone marrow mitochondria (Bottomley and Smithee, 1971) leading to impairment of heme synthesis (Beck et al., 1972) . Yunis (1973) observed ultrastructural damage to bone marrow mitochondria as a result of CAP therapy in patients. None of these effects, however, should apply to mature red cells since these have no mitochondria. CAP could be expected to produce no serious disruption of their metabolism. The results shown in Table 1 would support this contention. More direct effects of CAP on red cell membranes, such as those disruptions caused by certain antineoplastic drugs (Ben-Basaat et al., 1972; Schrier et al., 1974) , have not been reported. It is known that membrane renewal depends upon active glycolysis within the cells (Ben-Basaat et al., 1972) and that the type of membrane internalisations produced, for example, by primaquine, have a large effect on red cell osmotic fragility (George et al., 1966) .
Similar effects of CAP on red cell membranes, however, were not obvious in the current work. Sterile, defibrinated blood samples and heparinised samples treated with CAP were found to have closely similar ATP content and osmotic fragility cuaves, both before and after incubation at 37°C for 24 hours.
It is concluded, therefore, that CAP can be used routinely to preserve non-sterile blood samples free from the effects of bacterial action without detriment to the red cells, in normal patients and in patients with hereditary spherocytosis, so that post-incubation osmotic fragility measurements can be performed.
